Alemtuzumab - Campath; Lemtrada; MabCampath; CD52 monoclonal antibody, recombinant humanized rat -- Product Record

CD52 Mab, rDNA

      CD52 Mab, rDNA [BIO]
      CAMPATH [TR]
      Lemtrada [TR for MS indications]
      CAMPATH-1H [TR former reg. to Millenium]
      CAMPATH-1 [TR former; reg. to Wellcome Foundation]
      Alemtuzumab [FDA]
      CD52 monoclonal antibody, humanized [SY]
      LDP-03 [SY]
      MabCampath [TR Europe; reg. to Roche]
      NDC 50419-355-12 [NDC]

    molecular weight (kDa) = 150

    FDA Class:  Biologic BLA

    Year of approval (FDA) = 2001